Related references
Note: Only part of the references are listed.Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma
Angela Bononi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Population-based analysis of BAP1 germline variations in patients with uveal melanoma
Pauliina Repo et al.
HUMAN MOLECULAR GENETICS (2019)
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
Raffit Hassan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
BRCA1-associated protein (BAP1)-inactivated melanocytic tumors
Arianna J. Zhang et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2019)
Malignant pleural mesothelioma in Finland: regional and gender variation
Sanna Laaksonen et al.
ACTA ONCOLOGICA (2019)
Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors
Erin M. Garfield et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
Sebastian Walpole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma
A. Napolitano et al.
ONCOGENE (2016)
Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival
Francine Baumann et al.
CARCINOGENESIS (2015)
Toward an Improved Definition of the Tumor Spectrum Associated With BAP1 Germline Mutations
Thomas Wiesner et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Share Paper
